Evidence map›Paper›PMID 36033643›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients.

Charlotte Uro-Coste, Alba Atenza, Anne-Elisabeth Heng, Paul-Olivier Rouzaire, Cyril Garrouste

Open access · goldAbstract readLetter
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  2. Abatacept as maintenance therapy in kidney transplantation: a retrospective comparative study.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  3. Review
  4. Article
  5. Back to the Future With Co-Stimulation Blockade.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charlotte Uro-CosteDepartment of Nephrology, Dialysis and Transplantation, Clermont-Ferrand, France.
Alba AtenzaDepartment of Nephrology, Dialysis and Transplantation, Clermont-Ferrand, France.
Anne-Elisabeth HengDepartment of Nephrology, Dialysis and Transplantation, Clermont-Ferrand, France.
Paul-Olivier RouzaireEA 7453 CHELTER, Clermont-Ferrand, France.
Cyril GarrousteDepartment of Nephrology, Dialysis and Transplantation, Clermont-Ferrand, France.
Centre Hospitalier Universitaire de Clermont-Ferrand · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney TransplantationAbataceptCalcineurin InhibitorsGraft RejectionGraft SurvivalHumansImmunosuppressive AgentsTransplant RecipientsAbataceptCalcineurin InhibitorsImmunosuppressive Agentsabataceptbelatacept conversionCMV infectionimmunosuppressionkidney transplantrescue therapy

Identifiers

PMID36033643
PMCPMC9411423
OpenAlexW4291164820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.